ASH 2012: 10 Minute Break from the Excitement of the End of the Chemotherapy Era in CLL
Since I last posted I have interviewed Dr. Wiestner and Byrd, two of the most important researchers in moving ibrutinib forward. I also taped a long discussion with Dr. Wierda about CAR-T therapy among other things. Dr. Furman who did the phase 1 ibrutinib trial is next, then meeting Dr. Jeff Sharman.
This afternoon more lectures on ibrutinib, lenalidomide, and the first one on CAR-T.
Squeeze in the poster sessions and exhibit halls. And a visit with my sister-in-law.
Let me just summarize the news from ASH on CLL. You may not have heard it here first, but let me shout it out loud and clear.
The days of chemotherapy for CLL are ending.
Details to follow.
This afternoon more lectures on ibrutinib, lenalidomide, and the first one on CAR-T.
Squeeze in the poster sessions and exhibit halls. And a visit with my sister-in-law.
Let me just summarize the news from ASH on CLL. You may not have heard it here first, but let me shout it out loud and clear.
The days of chemotherapy for CLL are ending.
Details to follow.
Labels: ASH 2012, chemotherapy, Dr. Furman, Dr. Sharman, Dr. Wierda, ibrutinib, reporting
posted by Brian Koffman at
8:55 AM
2 Comments:
I follow your blog consistently, because I have you in my daily prayers during these last incredibly difficult years for you. I hope my prayers have helped in some small way.
This is the most wonderful news for all Who are either in the battle or are going to face it in the future. God Bless you Brian and all the Researchers and Doctors who have worked so hard for these amazing results.
Take good care,
Blessings Bunny
Anything that can stop chemotherapy for treating cancer is amazing. I can't wait to hear more about it. Maybe it can help other cancers.
Post a Comment
Subscribe to Post Comments [Atom]
<< Home